These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37661652)

  • 21. Diagnostic methods for dysthyroid optic neuropathy: A systematic review and analysis.
    Sio SWC; Chan BKT; Aljufairi FMAA; Sebastian JU; Lai KKH; Tham CCY; Pang CP; Chong KKL
    Surv Ophthalmol; 2024; 69(3):403-410. PubMed ID: 38007201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye disease.
    Berger M; Matlach J; Pitz S; Berres M; Axmacher F; Kahaly GJ; Brockmann MA; Müller-Eschner M
    Sci Rep; 2022 Apr; 12(1):6259. PubMed ID: 35428798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy.
    Garip-Kuebler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Hintschich CR
    Br J Ophthalmol; 2021 Jul; 105(7):1019-1023. PubMed ID: 32699051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of transethmoidal orbital decompression in patients with dysthyroid optic neuropathy].
    Grusha YO; Kochetkov PA; Ismailova DS; Svistushkin VM; Zhorzholadze NV; Spychak VY
    Vestn Otorinolaringol; 2020; 85(6):52-55. PubMed ID: 33474918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
    Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
    Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysthyroid Optic Neuropathy.
    Saeed P; Tavakoli Rad S; Bisschop PHLT
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S60-S67. PubMed ID: 29927882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy].
    Wang Y; Li YY; Yang N; Ma R; Xiao LH
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):416-423. PubMed ID: 28606262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment.
    Johnson BT; Jameyfield E; Aakalu VK
    Curr Opin Neurol; 2021 Feb; 34(1):116-121. PubMed ID: 33278144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Graves' Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study.
    Khong JJ; Finch S; De Silva C; Rylander S; Craig JE; Selva D; Ebeling PR
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2711-20. PubMed ID: 27055083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysthyroid optic neuropathy: a case series at a tertiary ophthalmic referral centre.
    Chung IY; Hardy TG; Khong JJ
    Eye (Lond); 2024 Apr; 38(6):1168-1172. PubMed ID: 38081935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vision-related quality of life tends to be more severely impaired in patients with dysthyroid optic neuropathy.
    Du Y; Ye H; Li K; Xiao X; Chen R; He JF; Yang H
    Curr Eye Res; 2014 May; 39(5):532-6. PubMed ID: 24215175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Edmunds MR; Boelaert K
    Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy.
    Tagami M; Honda S; Azumi A
    BMC Ophthalmol; 2020 Jan; 20(1):30. PubMed ID: 31952487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysthyroid Optic Neuropathy.
    Potvin ARGG; Pakdel F; Saeed P
    Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S65-S80. PubMed ID: 38054987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.
    Ponto KA; Diana T; Binder H; Matheis N; Pitz S; Pfeiffer N; Kahaly GJ
    J Endocrinol Invest; 2015 Jul; 38(7):769-77. PubMed ID: 25736545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding Understanding of Thyroid Eye Disease Manifestations to Include Hispanic and Black Patients.
    Goldstein T; Mostowy M; Tingley J; Rand G; Moon JY; Barmettler A
    Middle East Afr J Ophthalmol; 2022; 29(4):171-180. PubMed ID: 38162569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of surgical effect in active and inactive Dysthyroid Optic Neuropathy after Endoscopic Transnasal Medial Orbital Decompression.
    Lv X; Gao Y; Ma Y; Li C; Ren Y; Zhang Z; Bao Y; Su S; Lu R
    Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):281-293. PubMed ID: 37530848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatic visual evoked potentials identify optic nerve dysfunction in patients with Graves' orbitopathy.
    Yu Y; Shi B; Cheng S; Liu Y; Zhu R; You Y; Chen J; Pi X; Wang X; Jiang F
    Int Ophthalmol; 2022 Dec; 42(12):3713-3724. PubMed ID: 35635597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure lowering effect of orbital decompression is related to increased venous outflow in Graves orbitopathy.
    Onaran Z; Konuk O; Oktar SÖ; Yücel C; Unal M
    Curr Eye Res; 2014 Jul; 39(7):666-72. PubMed ID: 24502333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral dysthyroid compressive optic neuropathy responsive to teprotumumab.
    Hwang CJ; Nichols EE; Chon BH; Perry JD
    Eur J Ophthalmol; 2022 May; 32(3):NP46-NP49. PubMed ID: 33525898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.